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Abstract 
 
Doxorubicin is one of chemotherapeutic agent widely used in breast cancer treatment, 
but in high dose doxorubicin gives negative side effect, including vomit, nausea, immune 
suppression, and cardiac toxicity. This toxicity hopefully could be reduced by combination 
chemotherapy using natural herbs such as ciplukan herb. This research was conducted to 
explore cytotoxic activity of single ciplukan herbs ethanolic extract and its combination with 
doxorubicin on T47D breast cancer cells. Cytotoxic activity of ciplukan herbs ethanolic extract 
only and its combination with doxorubicin were tested on T47D cells using MTT assay to 
obtain IC50 value and combination index (CI), respectively. Single extract showed cytotoxic 
activity on T47D cells with IC50 value of was 160 µg/ml. Thus, combination treatment from 
ciplukan herbs ethanolic extract and doxorubicin showed synergistic effect (CI<1,0). This effect 
was reached at concentration of ciplukan herbs ethanolic extract-doxorubicin 80 μg/ml- 2 nM, 
80 μg/ml-4 nM, and 80 μg/ml-8 nM. This research indicated that ciplukan herbs ethanolic 
extract is potential to be applied as co-chemotherapeutic agent in breast cancer therapy.  
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INTRODUCTION 
 
As a high breast cancer occurences in the 
world, scientist are exploring and improving the 
best way to heal breast cancer. Doxorubicin (doxo) 
is one of chemotherapeutic agent widely used in 
the breast cancer therapy. However, therapy with 
doxo is limited because of its systemic toxicities, 
mainly cardiac toxicity, immune suppression 
(Wattanapitayakul et al., 2005), drug resistance 
(Davis et al., 2003), and apoptotic failure of cancer 
cells (Notarbartolo et al., 2005). Another side 
effects from doxo which often happened in therapy 
are vomit, nausea, hair loss. Combination 
chemotherapy is one of some approaches which 
can be applied to suppress doxo side effects. In 
combination chemotherapy, non-toxic or less toxic 
phytochemicals is combined with 
chemotherapeutics agents to enhance the efficacy 
together with a reduced toxicity to normal tissues 
(Sharma et al., 2004; Tyagi et al., 2004).  
Ciplukan (Physalis angulata) is one of 
natural herbs which exhibited cytotoxic activity on 
several cancer cells, including leukimia cells P-
388, nasopharing cancer cells KB-16, and lung 
cancer cells A-549 (Ismail and Alam, 2001). Wu 
et al. (2004) reported that ethanolic extract of P. 
angulata and P. peruviana had cytotoxic activity 
againts Hep G2 liver cancer cells.  
Physalis angulata herbs methanolic extract 
inhibited cell cycle progression by arresting cell at 
G2/M phase and inducing apoptosis on MCF-7 as 
well as MDA-MB 231 breast cancer cells (Hsieh et 
al., 2006). Physalis angulata also had been 
described contain some active compounds such as 
saponin, flavonoid, polyphenols, and steroid 
(Shingu et al., 1992). One of its active compounds 
is physalin. It is a seco steroid which could 
decrease pro-inflamatory cytokines production 
(Soares et al., 2005). Furthermore, from in vitro 
and in vivo studies, physalin B and physalin D 
showed strong cytotoxic activity and 
antiproliferative effect (Magalhães et al., 2006).  
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This study is aimed to evaluate synergistic 
effect of ciplukan (Physalis angulata) herbs 
ethanolic extract (EC) in combination with 
doxorubicin on T47D breast cancer cells. 
Hopefully, the outcomes of this study will give 
information in the development of breast cancer 
therapy.          
   
METHODOLOGY 
 
Ciplukan herbs ethanolic extract (EC) 
preparation 
Health, green, and 30-40 cm height ciplukan 
herbs were harvested from Besi, Sleman, 
Yogyakarta. The whole part of ciplukan herbs was 
used to produce ethanolic extract. Ciplukan herbs 
were collected and dried using oven under 
temperature 40
o
C. Dried herbs was then 
powderized with blender (National) and extracted 
using ethanol 70% (Merck). Rotary evaporation 
(Heidolp WB 2000) was done to concentrate 
ciplukan herbs ethanolic extract (EC).   
 
T47D cells culture 
T47D cell line was obtained from Cancer 
Chemoprevention Research Centre (CCRC), and it 
was gained from Prof. Tatsuo Takeya (Nara 
Institute of Science and Technology, Japan). T47D 
cells were grown in Dulbecco’s modified Eagle’s 
Medium (DMEM; Gibco), 10% fetal bovine serum 
(FBS; Gibco), and 1% Penicillin-Streptomycin 
(Gibco). The cells were incubated under 
temperature 37
o
C and 5% CO2. 
 
Cytotoxic assay using MTT 
T47D were seeded in 96-well plates (Iwaki) 
with 5x10
3
 cells/well and divided into control and 
treatment group. Single serial dilution of EC at 1, 
10, 50, 100, 250, 500, 750, 1000 µg/ml. EC (5 mg) 
was dissolved in Dimethyl sulfoxide (DMSO) as 
stock solution (1mg/ml) then diluted in culture 
medium until desired concentration. After 24 h 
incubation, culture medium was removed and cells 
were washed using PBS (Sigma). 5 mg/ml of MTT 
(Sigma) was diluted by culture medium (1 ml 
MTT stock add 10 ml culture medium) and 100 µl 
of it was added into every well. Then, the plate 
was incubated for 2-4 h until formazan was 
produced. MTT reaction was stopped by Sodium 
Dodecyl Sulfate (SDS) 10% in HCL 0,1 N 
(Merck). The plate was then covered with paper or 
aluminum foil and incubated in a dark place 
overnight, followed by incubation, shake for 10 
minutes and measured the absorbance using 
ELISA reader (Bio-Rad) at wave length of 595 
nm. The concentration applied on single agent was 
referred to IC50 value. Cytotoxic activity of 
doxorubicin was determined using MTT assay in 
previous study. Doxorubicin showed cytotoxic 
activity on T47D cells with IC50 value 16 nM 
(Fitriasari et al., 2009)   
 
Combination Index (CI) analysis.  
The CI was used to analyze synergistic, 
additive, or antagonistic effect of different drugs 
combinations (Zhao et al., 2004; Reynolds and 
Maurer, 2005). Briefly, variable rations of EC 
concentration e.g. 20, 40, 60, 80 µg/ml with 2, 4, 
6, 8 nM doxo, were used to treat T47D cells for 24 
h. Cells viability were detected by MTT assay as 
describe above on cytotoxic assay. Then data was 
analyzed using mutually exclusive equation to 
determine the CI. Each CI was calculated from the 
mean affected fraction at each EC ratio 
concentration using Chou and Talalay equation 
(1984); CI>1, CI=1, and CI<1 indicated 
antagonistic, additive, and synergistic effect 
respectively (Zhao et al., 2004; Reynolds and 
Maurer, 2005). 
 
Statatistical analysis.  
Absorbance data from cytotoxic assay were 
analyzed by Excell MS Office 2003 and semi-log 
analysis (SPSS 11.5) to obtain IC50 value. One 
way Anova was used to assess concentration 
(p<0.05) and post-hoc comparissons were made 
using Tukey’s significant different test.  
 
RESULT AND DISCUSSION 
 
Cytotoxic effect of ciplukan herbs 
ethanolic extract on T47D cells 
MTT assay was used to explore the effect of 
single treatment EC on T47D cells. The 
absorbance obtained from MTT assay is equal to 
T47D cells viability. Cytotoxic activity was 
presented by IC50 value. IC50 is a concentration 
where EC inhibit 50% of cell population. Single 
treatment of EC had cytotoxic activity on T47D 
cells with IC50 value 160 µg/ml (Figure 1). 
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Figure 1.      Ethanolic Extract (EC) effect on T47D cells viability. EC reduced T47D cells viability in dose 
dependent manner. T47D cells were incubated with EC at concentration 1, 10, 50, 100, 250, 
500, 750, and 1000 µg/ml during 24 h on temperature 37oC. T47D cells viability was measured 
using MTT assay. IC50 value was 160 µg/ml. Data shown was obtained from 3 replication, 
 (p<0,05).  
 
 
Combination effect of EC and doxo on 
T47D cells. 
Combination effect of EC-doxo was 
determined by MTT assay as described previously. 
EC and doxo concentration used in treatment was 
20, 40, 60, 80 µg/ml and 2, 4, 6, 8 nM, 
respectively. The result of combination treatment 
was performed using combination index (CI). 
Cytotoxic effect of EC-doxo combinations on 
T47D cells could be seen from their morphology 
under inverted microscope after 24 h treatment 
(Figure 2). T47D cells control was shown on 
figure 2A. It had regular morphology and well 
growth. Single treatment of EC at concentration of 
80 µg/ml (figure 2B) showed different morphology 
compared to control cells. Morphology changing 
of T47D cells also happened in the treatment of 
single doxo at concentration of 4 nM (figure 2C). 
However, there were some cells had the same 
morphology as the cells control. Combinational 
treatment of EC-doxo at concentration 80 µg/ml-4 
nM respectively made significant changing of 
T47D morphology compared to the cells control. 
The mortality of T47D cells were indicated as a 
round in shape cells which indicated mortality. 
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Figure 2.      EC-doxo combination effect on T47D cells morphology. Combination of EC-doxo could change 
T47D cells morphology. (A) T47D cell control; (B) EC single treatment at concentration 80 
µg/ml; (C) doxo single treatment at concentration 4 nM; (D) EC-doxo combination treatment 
at concentration 80 µg/ml-4 nM. T47D cells observation was performed using inverted 
microscope under 400x magnification.   
 
 
T47D viabilty after 24 h combination treatment of 
EC-doxo  presented in figure 3A. Cells viability 
decreased as increasing concentration of EC. It 
could be described that EC had strong influence on 
cell viability. T47D cells viability was 99,2% and 
54,18% because of single treatment doxo 4 nM 
and EC 80 µg/ml respectively. Then, treatment 
combination obtained 40,69% cells viability at 
same concentration. Further confirmation of this 
result was shown using CI (Figure 3B). 
 
     
 
Figure 3.          Combination effect of EC-doxo on T47D cells. (A) Combination effect of EC-doxo treatment 
on T47D cells viability at different concentration; (B) CI calculation based on Chou and 
Talalay equation. EC-doxo combination gives synergistic effect on T47D cells. 
 
 
A B 
C D 
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CI calculation (Table 1) resulted that combination 
EC-doxo showed synergistic effect at 
concentration EC-doxo 80 μg/ml- 2 nM, 80 μg/ml-
4 nM, dan 80 μg/ml-8 nM. These concentration 
obtained CI value under 1,0 which indicated 
synergistic effect. At low EC concentration, CI 
value was above 1,0 which indicated antagonist 
effect. As an increasing concentration of EC 
combined with doxo, CI value decreased. All 
results above indicated that EC could  increased 
doxo effication on T47D cells, it suggested that the 
proper combination of these agents are potential 
benefits in treating breast cancer. Furthermore, 
advance research is needed to confirm this result, 
especially in vivo studies. 
 
Table 1. Combination index (CI) value of combination EC-doxo on T47D cells 
EC concentration 
(µg/ml) 
doxo concentration (nM) 
2 (1/8 IC50) 4 (1/4 IC50) 6 (3/8 IC50) 8 (1/2 IC50) 
 
20 (1/8 IC50) 
 
2.58 
 
3.98 
 
4.70 
 
4.49 
40 (1/4 IC50) 2.19 3.19 3.56 3.87 
60 (3/8 IC50) 1.56 1.64 1.83 1.83 
80 (1/2 IC50) 0.80 0.52 1.06 0.67 
 
 
Doxorubicin is a chemotherapeutic agent 
which damaged double stranded DNA because of 
by intercalation on DNA base pairs and inhibition 
of topoisomerase IIα. DNA damage will activate 
kinase protein (ATM), and this will further which 
activate Chk2. Activation of Chk2 will make 
cdc25 inactive and cause inhibition of cdc2. Both 
proteins are needed in G and M phase of cell cycle. 
Inactivation of these proteins will lead G2/M arrest 
in cell (Drummond, 2007). G2/M arrest because of 
single doxo will be stronger when it was combined 
with EC.  
Hsieh et al. (2006) reported that P. angulata 
methanolic extract inhibit proliferation and induce 
apoptosis of MDA-MB 231 cancer cells. These 
effects happened trough the inhibition of cyclin B-
cdc2 complex protein. The other mechanism 
related to inhibition of cyclin B-cdc2 complex 
protein is higher level of p27
kip1
 protein. Inhibition 
of cyclin B-cdc2 complex protein will lead to 
G2/M arrest (Ismail and Alam, 2001).  
However, There were few studies which 
reported the apoptosis induction caused by because 
of P. angulata and related studies reported 
apoptosis effect because of Physalin sp. 
Chloroform extract of P. minima L. found to 
increased p53 and caspase-3 mRNA on NCI-H23 
cells (Leong et al., 2009) which caused induced 
apoptosis (Salvensen and Riedl, 2008). Water 
extract of P. peruviana was also found to increased 
the production of intracellular reactive oxygen 
species (ROS) such as hydrogen peroxide (H2O2), 
which had pro-oxidant activity (Hsieh et al., 
2006). High production of H2O2 would damage 
lipid, protein, as well as DNA and led to apoptosis 
process (Gosslau and Rensing, 2002). Taken 
together, combination of EC-doxo gave 
synergistics effect on T47D cells may because they 
have similar mechanism, trough cell cycle 
inhibition on G2/M phase and apoptosis induction. 
It is important to note that this mechanism is only 
the prediction based on the existing results at 
present and requires further more studies, like such 
as immunocytochemistry (ICC) and western blot 
to explore related protein in cell cycle and 
apoptosis. The positive outcomes of these studies 
still warrant further in vivo studies in pre-clinical 
breast cancer models to develop Ciplukan as a 
candidate for combinational therapy with doxo.  
 
CONCLUSION 
 
The conclusion of this study showed that 
combination between EC-doxo gave synergistic 
effect on T47D breast cancer cell, suggests that the 
proper combination of EC-doxo is potential 
benefits in treating breast cancer. 
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